ZA948353B - Novel (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans - Google Patents
Novel (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyransInfo
- Publication number
- ZA948353B ZA948353B ZA948353A ZA948353A ZA948353B ZA 948353 B ZA948353 B ZA 948353B ZA 948353 A ZA948353 A ZA 948353A ZA 948353 A ZA948353 A ZA 948353A ZA 948353 B ZA948353 B ZA 948353B
- Authority
- ZA
- South Africa
- Prior art keywords
- amino
- fluoro
- benzopyrans
- disubstituted
- carbamoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/144,671 US5420151A (en) | 1989-12-22 | 1993-10-28 | Chroman derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA948353B true ZA948353B (en) | 1995-05-02 |
Family
ID=22509617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA948353A ZA948353B (en) | 1993-10-28 | 1994-10-24 | Novel (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans |
Country Status (36)
| Country | Link |
|---|---|
| US (9) | US5420151A (ru) |
| EP (1) | EP0725779B1 (ru) |
| JP (1) | JP3089276B2 (ru) |
| CN (1) | CN1062269C (ru) |
| AT (1) | ATE203019T1 (ru) |
| AU (1) | AU687115B2 (ru) |
| BR (1) | BR9407910A (ru) |
| CA (1) | CA2173257C (ru) |
| CZ (1) | CZ284371B6 (ru) |
| DE (1) | DE69427704T2 (ru) |
| DK (1) | DK0725779T3 (ru) |
| EE (1) | EE03253B1 (ru) |
| ES (1) | ES2160640T3 (ru) |
| FI (1) | FI961809A (ru) |
| GR (1) | GR3036816T3 (ru) |
| HK (1) | HK1002898A1 (ru) |
| HR (1) | HRP940890B1 (ru) |
| HU (1) | HUT75060A (ru) |
| IL (1) | IL111365A (ru) |
| IS (1) | IS1904B (ru) |
| LV (1) | LV12811B (ru) |
| MY (1) | MY111616A (ru) |
| NO (1) | NO314146B1 (ru) |
| NZ (1) | NZ275176A (ru) |
| PL (1) | PL178840B1 (ru) |
| PT (1) | PT725779E (ru) |
| RU (1) | RU2142951C1 (ru) |
| SA (1) | SA94150317B1 (ru) |
| SG (1) | SG52320A1 (ru) |
| SI (1) | SI0725779T1 (ru) |
| SK (1) | SK280527B6 (ru) |
| TW (1) | TW399049B (ru) |
| UA (1) | UA44717C2 (ru) |
| WO (1) | WO1995011891A1 (ru) |
| YU (1) | YU49048B (ru) |
| ZA (1) | ZA948353B (ru) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616610A (en) * | 1989-12-22 | 1997-04-01 | Astra Aktiebolag | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans |
| IL114760A (en) * | 1991-02-08 | 1997-11-20 | Lilly Co Eli | Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto |
| US5719155A (en) * | 1993-11-10 | 1998-02-17 | Japan Tobacco Inc. | Chroman derivative and pharmaceutical use thereof |
| SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
| US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| SE9701438D0 (sv) | 1997-04-17 | 1997-04-17 | Astra Ab | A new process |
| SE510305C2 (sv) * | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
| US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
| SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| US5962488A (en) | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
| US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
| US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| IL156595A0 (en) | 2001-01-16 | 2004-01-04 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| US7032572B2 (en) * | 2002-06-04 | 2006-04-25 | Ford Global Technologies, Llc | Method for controlling an engine to obtain rapid catalyst heating |
| SE0301796D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
| SE0301795D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
| US20050032873A1 (en) * | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
| US20060205807A1 (en) * | 2005-02-16 | 2006-09-14 | Wyeth | Amino-chroman compounds and methods for preparing same |
| US8846742B2 (en) * | 2006-02-14 | 2014-09-30 | The Trustees Of Columbia University In The City Of New York | Neuronal pain pathway modulators |
| PT103901B (pt) * | 2006-12-12 | 2012-03-01 | Portela & Ca Sa | Processo catalítico para hidrogenação assimétrica. |
| US8473062B2 (en) * | 2008-05-01 | 2013-06-25 | Autonomic Technologies, Inc. | Method and device for the treatment of headache |
| US8412336B2 (en) | 2008-12-29 | 2013-04-02 | Autonomic Technologies, Inc. | Integrated delivery and visualization tool for a neuromodulation system |
| US8494641B2 (en) | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
| US9320908B2 (en) * | 2009-01-15 | 2016-04-26 | Autonomic Technologies, Inc. | Approval per use implanted neurostimulator |
| US20100185249A1 (en) * | 2009-01-22 | 2010-07-22 | Wingeier Brett M | Method and Devices for Adrenal Stimulation |
| EA201990400A1 (ru) | 2016-07-29 | 2019-07-31 | Суновион Фармасьютикалз, Инк. | Соединения и композиции и их применение |
| MA45795A (fr) * | 2016-07-29 | 2019-06-05 | Sunovion Pharmaceuticals Inc | Composés et compositions, et utilisations associées |
| CA2972203C (en) | 2017-06-29 | 2018-07-17 | Exxonmobil Upstream Research Company | Chasing solvent for enhanced recovery processes |
| CA2974712C (en) | 2017-07-27 | 2018-09-25 | Imperial Oil Resources Limited | Enhanced methods for recovering viscous hydrocarbons from a subterranean formation as a follow-up to thermal recovery processes |
| EP3661929B1 (en) | 2017-08-02 | 2021-07-14 | Sunovion Pharmaceuticals Inc. | Isochroman compounds and uses thereof |
| CA2978157C (en) | 2017-08-31 | 2018-10-16 | Exxonmobil Upstream Research Company | Thermal recovery methods for recovering viscous hydrocarbons from a subterranean formation |
| CA2983541C (en) | 2017-10-24 | 2019-01-22 | Exxonmobil Upstream Research Company | Systems and methods for dynamic liquid level monitoring and control |
| US11136304B2 (en) | 2019-03-14 | 2021-10-05 | Sunovion Pharmaceuticals Inc. | Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
| US12007369B2 (en) * | 2021-04-01 | 2024-06-11 | Saudi Arabian Oil Company | Residual corrosion inhibitor monitoring |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795874A (fr) * | 1972-02-25 | 1973-08-23 | Glaxo Lab Ltd | Procede de preparation d'esters optiquement actifs d'alpha-amino-acides |
| JPS60152425A (ja) * | 1984-01-20 | 1985-08-10 | Oyo Seikagaku Kenkyusho:Kk | ラセミ体の新規な光学分割法 |
| US4683223A (en) * | 1985-09-09 | 1987-07-28 | Warner-Lambert Company | N6 -Benzopyrano-and benzothiopyrano adenosines and methods of use |
| PH22522A (en) * | 1985-09-03 | 1988-10-17 | Ciba Geigy Ag | 3-amino-dihydro-1-benzopyrans and benzothiopyrans, their pharmaceutical compositions and method of using said compounds |
| FR2593504B1 (fr) * | 1986-01-30 | 1988-12-09 | Ile De France | Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques |
| US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
| SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| US4971982A (en) * | 1987-07-06 | 1990-11-20 | Hoffmann-La Roche Inc. | Benzopyran derivatives |
| US5214156A (en) * | 1988-03-25 | 1993-05-25 | The Upjohn Company | Therapeutically useful tetralin derivatives |
| US5021432A (en) * | 1988-04-26 | 1991-06-04 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzopyran compound and its pharmaceutical use |
| US5026707A (en) * | 1988-05-23 | 1991-06-25 | Eli Lilly And Company | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
| CA1335591C (en) * | 1988-05-23 | 1995-05-16 | James Arthur Nixon | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
| DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US5225596A (en) * | 1989-01-09 | 1993-07-06 | The Upjohn Company | Halo substituted aminotetralins |
| ZA901277B (en) * | 1989-02-27 | 1991-10-30 | Lilly Co Eli | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| US5306830A (en) * | 1989-04-27 | 1994-04-26 | The Upjohn Company | Substituted 3-amino chromans |
| JP2785879B2 (ja) * | 1989-05-31 | 1998-08-13 | ジ・アップジョン・カンパニー | 治療学的に有用な２―アミノテトラリン誘導体 |
| DE3942418A1 (de) * | 1989-12-21 | 1991-06-27 | Guenther Strecker | Gestellstab |
| SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
| DE69124868T2 (de) * | 1990-08-15 | 1997-07-10 | Lilly Co Eli | Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane |
| HRP920935A2 (en) * | 1991-10-08 | 1995-08-31 | Astra Ab | New therapeutically active compound |
-
1993
- 1993-10-28 US US08/144,671 patent/US5420151A/en not_active Expired - Fee Related
-
1994
- 1994-09-09 US US08/304,108 patent/US5500425A/en not_active Expired - Fee Related
- 1994-10-23 IL IL11136594A patent/IL111365A/xx not_active IP Right Cessation
- 1994-10-24 IS IS4226A patent/IS1904B/is unknown
- 1994-10-24 ZA ZA948353A patent/ZA948353B/xx unknown
- 1994-10-25 MY MYPI94002832A patent/MY111616A/en unknown
- 1994-10-26 RU RU96110205A patent/RU2142951C1/ru not_active IP Right Cessation
- 1994-10-26 SG SG1996002730A patent/SG52320A1/en unknown
- 1994-10-26 PT PT94931725T patent/PT725779E/pt unknown
- 1994-10-26 UA UA96041644A patent/UA44717C2/uk unknown
- 1994-10-26 SI SI9430386T patent/SI0725779T1/xx unknown
- 1994-10-26 JP JP07512559A patent/JP3089276B2/ja not_active Expired - Fee Related
- 1994-10-26 CZ CZ961114A patent/CZ284371B6/cs not_active IP Right Cessation
- 1994-10-26 NZ NZ275176A patent/NZ275176A/en unknown
- 1994-10-26 ES ES94931725T patent/ES2160640T3/es not_active Expired - Lifetime
- 1994-10-26 BR BR9407910A patent/BR9407910A/pt not_active Application Discontinuation
- 1994-10-26 EE EE9600049A patent/EE03253B1/xx not_active IP Right Cessation
- 1994-10-26 SK SK436-96A patent/SK280527B6/sk unknown
- 1994-10-26 WO PCT/SE1994/001010 patent/WO1995011891A1/en active IP Right Grant
- 1994-10-26 DK DK94931725T patent/DK0725779T3/da active
- 1994-10-26 TW TW083109886A patent/TW399049B/zh not_active IP Right Cessation
- 1994-10-26 CA CA002173257A patent/CA2173257C/en not_active Expired - Fee Related
- 1994-10-26 PL PL94314086A patent/PL178840B1/pl not_active IP Right Cessation
- 1994-10-26 AT AT94931725T patent/ATE203019T1/de not_active IP Right Cessation
- 1994-10-26 DE DE69427704T patent/DE69427704T2/de not_active Expired - Fee Related
- 1994-10-26 EP EP94931725A patent/EP0725779B1/en not_active Expired - Lifetime
- 1994-10-26 CN CN94194312A patent/CN1062269C/zh not_active Expired - Fee Related
- 1994-10-26 HU HU9601103A patent/HUT75060A/hu unknown
- 1994-10-26 AU AU80697/94A patent/AU687115B2/en not_active Ceased
- 1994-10-28 YU YU62294A patent/YU49048B/sh unknown
- 1994-10-28 HR HR940890A patent/HRP940890B1/xx not_active IP Right Cessation
- 1994-11-16 SA SA94150317A patent/SA94150317B1/ar unknown
-
1995
- 1995-05-26 US US08/451,983 patent/US5650524A/en not_active Expired - Fee Related
- 1995-05-30 US US08/455,113 patent/US5656657A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,494 patent/US5646309A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,225 patent/US5639772A/en not_active Expired - Fee Related
- 1995-05-30 US US08/452,982 patent/US5641807A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,630 patent/US5639784A/en not_active Expired - Fee Related
- 1995-05-30 US US08/453,648 patent/US5656658A/en not_active Expired - Fee Related
-
1996
- 1996-04-26 FI FI961809A patent/FI961809A/fi not_active IP Right Cessation
- 1996-04-26 NO NO19961687A patent/NO314146B1/no unknown
-
1998
- 1998-03-10 HK HK98101998A patent/HK1002898A1/xx not_active IP Right Cessation
-
2001
- 2001-09-26 LV LVP-01-138A patent/LV12811B/xx unknown
- 2001-10-05 GR GR20010401676T patent/GR3036816T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9601103D0 (en) | Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes | |
| IL104006A0 (en) | Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them | |
| BG104356A (en) | Compounds based on azabenzimidazole for the modulation of serin/treonin protein kinase function | |
| CA2012876A1 (en) | Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances | |
| AU2626492A (en) | 2- aminomethyl-chromans | |
| BG100830A (en) | Naphthylamides as central nervous system agents | |
| TW225532B (ru) | ||
| UA27749C2 (ru) | Замещенные циклопропиламино-1,3, 5-триазины, их оптические изомеры, рацемические смеси или их соли присоединения нетоксичных фармацевтически приемлемых кислот, имеющих фармакологическую активность, способ их получения | |
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| IL114599A0 (en) | Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them | |
| YU211087A (en) | Process for obtaining new n-substituted benzimidazolic derivatives | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
| MY107354A (en) | Substituted cyclohexenes as central nervous system agents | |
| IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
| UA37211C2 (ru) | Производные 1,4-дигидропиридина в форме рацемата или энантиомеров, 2-хлор-3-цианобензальдегид как промежуточный продукт для их получения и фармацевтическая композиция, обладающая антагонистической активностью относительно катионов кальция | |
| IL115004A (en) | Pharmaceutical compositions containing substituted 6-amino-4H-pyrans certain novel such compounds and their preparation | |
| AU5768298A (en) | Use of benzoylalkyl-1,2,3,6-tetrahydropyridins | |
| CA2154485A1 (en) | Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders | |
| MX9703610A (es) | Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas. | |
| MX9709684A (es) | Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel. |